| 发明名称 |
QUINONE DERIVATIVE 2,3-DIMETHOXY-5-METHYL-6-(10-HYDROXYDECYL)-1,4-BENZOQUINONE FOR THE TREATMENT OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS |
| 摘要 |
The present invention relates to pharmaceuticals and uses thereof directed to the curative treating or preventing of Primary Progressive Multiple Sclerosis (PP-MS), by using 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (Idebenone) as the active agent. |
| 申请公布号 |
EP2424513(B1) |
申请公布日期 |
2015.05.20 |
| 申请号 |
EP20090795720 |
申请日期 |
2009.12.18 |
| 申请人 |
SANTHERA PHARMACEUTICALS (SCHWEIZ) AG;THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
发明人 |
MEIER, THOMAS;BIELEKOVA, BIBIANA;MCFARLAND, HENRY, F. |
| 分类号 |
A61K31/122;A61P25/00 |
主分类号 |
A61K31/122 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
